Annis Gardner Whiting Capital Advisors LLC Lowers Stock Holdings in Lam Research Corporation $LRCX

Annis Gardner Whiting Capital Advisors LLC lessened its holdings in shares of Lam Research Corporation (NASDAQ:LRCX) by 26.9% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 5,690 shares of the semiconductor company’s stock after selling 2,090 shares during the quarter. Annis Gardner Whiting Capital Advisors LLC’s holdings in Lam Research were worth $763,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. IMG Wealth Management Inc. acquired a new stake in Lam Research in the 2nd quarter worth about $26,000. Howard Hughes Medical Institute acquired a new position in shares of Lam Research during the 2nd quarter valued at about $27,000. Sound Income Strategies LLC purchased a new position in shares of Lam Research during the 3rd quarter worth about $41,000. Tripletail Wealth Management LLC acquired a new stake in shares of Lam Research in the third quarter worth approximately $44,000. Finally, Strategic Wealth Investment Group LLC purchased a new stake in Lam Research in the second quarter valued at approximately $29,000. Institutional investors and hedge funds own 84.61% of the company’s stock.

Insider Activity

In other news, Director Bethany Mayer sold 1,298 shares of Lam Research stock in a transaction dated Monday, November 3rd. The stock was sold at an average price of $159.99, for a total transaction of $207,667.02. Following the sale, the director directly owned 1,652 shares of the company’s stock, valued at approximately $264,303.48. The trade was a 44.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Douglas R. Bettinger sold 40,080 shares of the stock in a transaction dated Friday, November 14th. The shares were sold at an average price of $150.60, for a total value of $6,036,048.00. Following the completion of the transaction, the chief financial officer directly owned 987,237 shares of the company’s stock, valued at $148,677,892.20. This represents a 3.90% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 41,408 shares of company stock valued at $6,248,501 over the last 90 days. Insiders own 0.31% of the company’s stock.

Lam Research Stock Up 0.5%

NASDAQ LRCX opened at $239.58 on Thursday. The company has a quick ratio of 1.60, a current ratio of 2.21 and a debt-to-equity ratio of 0.37. Lam Research Corporation has a fifty-two week low of $56.32 and a fifty-two week high of $243.99. The business has a 50 day moving average price of $183.31 and a two-hundred day moving average price of $144.37. The stock has a market cap of $300.92 billion, a PE ratio of 52.77, a P/E/G ratio of 3.01 and a beta of 1.77.

Lam Research (NASDAQ:LRCX) last posted its earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 EPS for the quarter, topping analysts’ consensus estimates of $1.17 by $0.10. The business had revenue of $5.34 billion for the quarter, compared to analysts’ expectations of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The business’s revenue for the quarter was up 22.1% compared to the same quarter last year. During the same period in the previous year, the company posted $0.91 earnings per share. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. As a group, sell-side analysts predict that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, January 7th. Shareholders of record on Wednesday, December 3rd were given a $0.26 dividend. This represents a $1.04 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend was Wednesday, December 3rd. Lam Research’s dividend payout ratio is presently 22.91%.

Analysts Set New Price Targets

A number of brokerages have weighed in on LRCX. Morgan Stanley set a $211.00 price target on shares of Lam Research in a report on Thursday, January 15th. Barclays set a $195.00 target price on Lam Research in a research report on Thursday, January 15th. Jefferies Financial Group reissued a “buy” rating and set a $200.00 price target (up previously from $175.00) on shares of Lam Research in a research report on Monday, December 15th. Stifel Nicolaus raised their price objective on Lam Research from $160.00 to $250.00 and gave the stock a “buy” rating in a report on Wednesday, January 14th. Finally, Dbs Bank boosted their target price on Lam Research from $119.40 to $184.20 in a report on Monday, October 27th. One analyst has rated the stock with a Strong Buy rating, twenty-seven have given a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $204.26.

More Lam Research News

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Q2 earnings and revenue beat consensus — Lam reported $1.27 EPS vs. $1.17 expected and $5.34B revenue vs. $5.23B expected, with margins and ROE notably strong (y/y revenue +22%). Lam Research (LRCX) Q2 Earnings and Revenues Beat Estimates
• Positive Sentiment: Raised Q3 guidance: EPS guide $1.25–1.45 (above $1.20 consensus) and revenue guide $5.4–6.0B (above ~$5.3B consensus) — investors view this as confirmation of stronger WFE demand. Lam Research Corporation Reports Financial Results for the Quarter Ended December 28, 2025
• Positive Sentiment: Management and news outlets cite rising enterprise orders and strong chipmaking-tool demand underpinning the upbeat forecast — a demand-driven beat/guide is taken as durable upside for revenue visibility. Lam Research forecasts strong quarterly results on chipmaking tool demand
• Positive Sentiment: Analyst interest and upgrades: coverage notes (including Evercore/other firms) and at least one upgrade have lifted sentiment and trading interest. Lam Research (NASDAQ:LRCX) Stock Price Up 2.3% After Analyst Upgrade
• Positive Sentiment: High-profile bullish commentary — Jim Cramer and others highlight a supply shortage and structural tailwinds from AI and advanced-node spending, supporting a longer-term bullish case. Lam Research (LRCX) Has a Shortage That Can’t Be Met, Says Jim Cramer
• Neutral Sentiment: Positive media and analyst previews (Zacks, 24/7 Wall St.) framed expectations ahead of results — helpful for market context but not new fundamentals. Bull of the Day: Lam Research (LRCX)
• Negative Sentiment: Valuation and volatility concerns — commentary warns that LRCX is at record highs and has a history of sharp corrections; investors should weigh upside vs. PE/volatility risk. Why Record Highs For LRCX Stock May Face A Reality Check In 2026
• Negative Sentiment: Geopolitical/China exposure — coverage notes that China-related demand or regulatory developments could weigh on the outlook despite AI tailwinds. Lam Research leans on AI tailwinds as China weighs on outlook

Lam Research Company Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.